About
Alumis, Inc. develops targeted therapies for immune-mediated diseases using a precision approach powered by a proprietary data analytics platform to optimize patient outcomes.
Explore Alumis, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.